Hck
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Hck-IN-1 REF: TM-T11538CAS: 1473404-51-1 | 98.29% | 128.00 €~1,323.00 € | Mon 15 Jul 24 |
| PP121 REF: TM-T2415CAS: 1092788-83-4 | 99.67% | 55.00 €~344.00 € | Mon 22 Jul 24 |
| TL02-59 REF: TM-T13186CAS: 1315330-17-6 | 98% | 104.00 €~1,132.00 € | Mon 16 Sep 24 |
Hck-IN-1
CAS:1473404-51-1
Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; >20 μM for Hck alone. Potent HIV-1 Nef …
Formula:
C16H11ClN6O3S
Purity:
98.29%
Color and Shape:
Solid
Molecular weight:
402.81
Ref: TM-T11538
| 1mg | 128.00 € | ||
| 1ml | 296.00 € | ||
| 2mg | 176.00 € | ||
| 5mg | 270.00 € | ||
| 10mg | 423.00 € | ||
| 25mg | 697.00 € | ||
| 50mg | 976.00 € | ||
| 100mg | 1,323.00 € |
Estimated delivery in United States, on Monday 15 Jul 2024
PP121
CAS:1092788-83-4
PP-121 is a multi-targeted inhibitor of PDGFR (IC50: 2 nM), Hck (IC50: 8 nM), mTOR …
Formula:
C17H17N7
Purity:
99.67%
Color and Shape:
Solid
Molecular weight:
319.36
Ref: TM-T2415
| 5mg | 60.00 € | ||
| 10mg | 89.00 € | ||
| 25mg | 155.00 € | ||
| 50mg | 237.00 € | ||
| 100mg | 344.00 € | ||
| 1ml*10 (DMSO) | 55.00 € |
Estimated delivery in United States, on Monday 22 Jul 2024
TL02-59
CAS:1315330-17-6
TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
Formula:
C32H34F3N5O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
609.64
Ref: TM-T13186
| 1mg | 104.00 € | ||
| 1ml | 281.00 € | ||
| 5mg | 212.00 € | ||
| 10mg | 347.00 € | ||
| 25mg | 584.00 € | ||
| 50mg | 832.00 € | ||
| 100mg | 1,132.00 € |
Estimated delivery in United States, on Monday 16 Sep 2024
